The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin.
about
Central and peripheral administration of secretin inhibits food intake in mice through the activation of the melanocortin systemPharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal modelsCentral nervous system mechanisms linking the consumption of palatable high-fat diets to the defense of greater adiposityInconsistencies in the assessment of food intakeCholecystokinin and hypothalamic corticotrophin-releasing factor participate in endotoxin-induced hypophagiaThe cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight.Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.Vagal control of satiety and hormonal regulation of appetiteGastrointestinal satiety in animals other than man.Cholecystokinin-octapeptide constricts guinea-pig and human airways.Gut hormones in the control of appetite.Peripheral and central signals in the control of eating in normal, obese and binge-eating human subjects.PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement.A brief review of salient factors influencing adult eating behaviour.Central control of body weight and appetite.Extrinsic primary afferent signalling in the gut.Appetite regulation: the role of peptides and hormones.Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target.Role of cholecystokinin in the regulation of satiation and satiety in humans.The effect of infused nutrients and absorbed foods on daily food intake in rats.Effects of amylin on appetite regulation and memory.Passive overconsumption. Fat intake and short-term energy balance.Quipazine reduces food intake in the rat by activation of 5-HT2-receptors.2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor.Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329.Reduction of food intake by central administration of cholecystokinin octapeptide in the rat is dependent upon inhibition of brain peptidases.Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.Regulation of nutrient supply: the brain and appetite control.Involvement of cholecystokinin in food intake: I. Concentrations of cholecystokinin-like immunoreactivity in the cerebrospinal fluid of male rats.Devazepide, a CCKA receptor antagonist, impairs the acquisition of conditioned reward and conditioned activity.Evidence for a high-affinity uptake system for cholecystokinin octapeptide (CCK8) in rat cortical synaptosomes.Meal-Sensing Signaling Pathways in Functional Dyspepsia.
P2860
Q24601868-02C716B1-2ED8-4314-890E-CB726C7804B2Q24673072-70FC05FE-630B-4BDE-BC1C-F35382AE9D69Q26853424-EE23EE07-6DC7-49C5-97AD-8DBB3EA033FEQ27027737-8286F8A5-F6F0-4343-98D8-F0466A870BAEQ28578149-00518ADE-2952-4491-A622-EE6E776CD804Q33835949-D91B8BA5-C6C0-41AC-858B-312BF4FF86DFQ34378911-33B74029-6983-41B9-9B90-87704702DDEBQ35587505-2CB06DFB-B788-46B1-9734-21B07951CA11Q35747897-DC09FEB0-F32D-4D09-8DE6-185ED80090F0Q35756568-49128FF6-D9EF-4E36-95EB-ECD2622F1CE7Q35796674-F6C76AE9-1472-47C0-A98B-20AF26A483DAQ35895543-2A343B49-5974-4E02-A4A8-8A0FA5E30CD7Q36094371-7D2E241F-CB4A-4CF4-8FEB-A046A5258C57Q36408333-4122312A-283D-499B-A055-DD11D063BE5BQ36979763-680EE0BC-12BB-439D-9A94-7F81BF6F955DQ38084452-7DE189E7-17C5-4C7D-AA79-DF9A4E07EC32Q38668705-FDA98F7A-5A75-411E-B86D-C591B4441A37Q38828407-BC3983F6-D058-4AB6-AE96-EBCC2FB657B0Q40753306-47B903FE-10D0-43B0-B0E4-FB4752F18D01Q41000579-AEFF3FB3-B5E6-4473-AB4D-AA5219FFF5EDQ41143340-CA0918C6-5E06-4FEB-A032-F544A36DEB5EQ41611317-109B72A3-76C8-43C4-AD7B-D0180656D397Q41852535-A20EAAAB-D9AF-4E84-941F-B22B0E35FAACQ41903306-4A5A729A-59C2-489C-B211-FE70E7EA665EQ42563833-813C5320-C263-436D-B532-386540042EBCQ42848281-7D93EC47-E092-4E23-A21D-6F1617E64F94Q45116714-F3C527AA-5CA9-432E-80E8-51B3CB46CF44Q48096019-11C01D77-3BA4-4949-B3DF-00FBD7B2B7EAQ48839451-6953B641-57D3-43E6-AB4D-C506484A75EBQ52203787-E2DCF773-5EC1-4CE1-B517-EE795AAF087AQ54174405-6B6D366A-558D-46E0-8D3B-3196E1F7FCF8Q54939638-67D11194-F734-4539-854A-071F55D48CEC
P2860
The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
The cholecystokinin receptor a ...... of endogenous cholecystokinin.
@en
The cholecystokinin receptor a ...... of endogenous cholecystokinin.
@nl
type
label
The cholecystokinin receptor a ...... of endogenous cholecystokinin.
@en
The cholecystokinin receptor a ...... of endogenous cholecystokinin.
@nl
prefLabel
The cholecystokinin receptor a ...... of endogenous cholecystokinin.
@en
The cholecystokinin receptor a ...... of endogenous cholecystokinin.
@nl
P2093
P2860
P1476
The cholecystokinin receptor a ...... of endogenous cholecystokinin.
@en
P2093
P2860
P356
10.1111/J.1476-5381.1988.TB11407.X
P407
P577
1988-01-01T00:00:00Z